Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials

por Nelson, M, Amaya, G, Clumeck, N, Arns Da Cunha, C, Jayaweera, D, Junod, P, Taisheng, L, Tebas, P, Stevens, M, Buelens, A, Vanveggel, S, Boven, K
Publicado 2010